STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT
Cancer Medicine · 2026-05 · 15 (5)
DOI: 10.1002/cam4.71862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.04.2026. Verfasst von Kuangyu Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, School of Stomatology, Harbin, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Wnt Signaling Pathway, Mouth Neoplasms, Antigens, Neoplasm. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Objective
The present study aimed to investigate the expression and biological behaviour of the six‐transmembrane epithelial antigen of the prostate 1 (STEAP1) in oral squamous cell carcinoma (OSCC), and to further analyse its underlying mechanisms. Material and Methods Western blot and immunohistochemistry were used to detect protein expression. After overexpression of STEAP1 in OSCC cells by plasmid transfection, cell proliferation, migration, and invasion abilities were assessed using CCK‐8, scratch, and Transwell assays, respectively, and ROS levels were detected using the corresponding kits. Finally, the expression changes of EMT and Wnt/β‐catenin pathway‐related proteins were analysed by Western blot.
Result
Western blot (WB) and immunohistochemical (IHC) analyses showed that STEAP1 was significantly underexpressed ( p < 0.0001) in oral squamous cell carcinoma (OSCC) tissues and cell lines (SAS, Tca‐8113, SCC15) compared to normal controls. Functional experiments showed that overexpression of STEAP1 effectively inhibited the proliferation ( p < 0.001), migration ( p < 0.0001), and invasion ( p < 0.001) abilities of OSCC cells (SAS, Tca‐8113) and reduced intracellular ROS levels ( p < 0.0001). Molecularly, STEAP1 overexpression up‐regulated E‐cadherin ( p < 0.01) and down‐regulated N‐cadherin ( p < 0.05), inhibiting the EMT process; meanwhile, it decreased the protein levels of β‐catenin ( p < 0.05), Axin2 ( p < 0.05), and c‐Myc ( p < 0.05), as well as the protein levels of the p‐ GSK3β/T‐GSK3β ratio ( p < 0.05), but there was no significant change in total GSK3β protein, suggesting inhibition of the Wnt/β‐catenin pathway.
Conclusion
STEAP1 is downregulated in OSCC and suppresses malignant phenotypes of OSCC cells in vitro, with effects associated with EMT‐related changes and attenuation of Wnt/β‐catenin‐associated signalling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, School of Stomatology, Harbin, China.
ORCID-Profile: Kuangyu Jin
Förderung
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Jin, K., Liu, S., Jin, H., Zhang, D., Lu, R., & Wang, W. (2026). STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71862
Vancouver
Jin K, Liu S, Jin H, Zhang D, Lu R, Wang W. STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71862
BibTeX
@article{Jin2026,
author = {Jin, Kuangyu and Liu, Shitong and Jin, Hui and Zhang, Dong and Lu, Runze and Wang, Wei},
title = {STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/cam4.71862}
}
EUVIMED